Welcome to our dedicated page for A SPAC II Acquisition SEC filings (Ticker: ASCBF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on A SPAC II Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into A SPAC II Acquisition's regulatory disclosures and financial reporting.
A SPAC II Acquisition Corp., a British Virgin Islands blank check company, filed its annual report describing its status and risks while it continues searching for a merger target in high‑growth “New Economy” sectors such as PropTech and FinTech.
The SPAC has repeatedly extended its deadline and now has until August 5, 2027 to complete a business combination after multiple shareholder-approved charter amendments and large redemptions, including 18,003,605 Class A shares in 2023 and 1,608,417 in 2024. As of February 17, 2026, it had 5,243,594 Class A and 100,000 Class B shares outstanding.
The company was delisted from Nasdaq in 2024 for not meeting continued listing standards and its securities now trade over the counter. As of December 31, 2025, it reported only $135 in cash outside the trust and a working capital deficit of $645,353, and its auditor noted substantial doubt about its ability to continue as a going concern if no deal is completed by the deadline. The filing also highlights extensive legal and regulatory risks tied to its China connections, potential China-based targets, PRC rules, HFCAA and PCAOB oversight, and U.S. foreign investment review by CFIUS.